vimarsana.com

தொழிற்சங்கம் ஆரோக்கியம் அமைச்சகம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As COVID-19 positivity rate drops to 16 98% in India, this is the perfect time to prepare for the third wave!

#CovidAsia2ndWave: As Covid engulfs South Asia, Xi claims normalcy ; What is China s covid reality?

China s neighbors like India, Japan and South Asian countries are reporting huge surge meanwhile Mainland China has no more 12 cases as far as the Chinese National Health Commission is concerned. Lack of free press and transparency in the Communist regime has make it immensely difficult to find out the truth behind XI s fallacies and narratives.

As Covid second wave engulfs South Asia, Xi spins 7 cases lies; What is China s covid reality?

Xi Jinping India has been battling the second wave Covid Tsunami and similarly its immediate neighbors have seen a rise in increasing covid cases. Afghanistan, Nepal, Bangladesh, Sri Lanka, Pakistan are recording sharply rising infections during the month of April. The Union Health Ministry of India reported as many as 3,43,144 new COVID-19 cases in the last 24 hrs in the country. The grim realities of acute shortages have left the country in shock. Healthcare and medical infrastructure has collapsed nationwide and doctors and medical team are living on the edge in trying to provide treatment to the covid patients. The World Health Organization (WHO) raised alarm about the B.1.617 of the Covid-19 variant which was first identified in India and designated it as one of global concern that requires more tracking and analysis. However a major concern is that WHO has been blindly trusting whatever China is telling them for the past few months. One country that seems to be showing its

WHO Warns Against Use of Ivermectin for Treating COVID-19; some Indian states approve use

DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence With no fixed therapeutic regimen to treat COVID-19, the stand on drugs recommended for the treatment of the SARS-CoV-2 infection has witnessed see-sawing since 2020. Now, the World Health Organization (WHO) has stated that it does not recommend the use of Ivermectin, a commonly prescribed and inexpensive anti-parasitic drug, for the treatment of the viral disease. Dr. Soumya Swaminathan, Chief Scientist at WHO, tweeted on Tuesday, stating that the international health body recommended against the use of Ivermectin for treating COVID-19 patients (with the exception of clinical trials). The tweet comes at a time when several countries, and also many states in India, have approved the use of the drug for treating the respiratory illness.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.